| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.82B | +10.5% |
| Gross profit | ¥0.34B | — |
| Operating income | ¥0.09B | — |
| Net income | ¥0.07B | +153.7% |
| Gross margin | 41.1% | Net margin 8.9% |
| Revenue Q/Q | +37.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.48B | 58.9% |
| R&D | ¥0.00B | 0.3% |
| SG&A | ¥0.22B | 26.5% |
| Tax & other | ¥0.02B | 2.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学 ・ 普蕊斯 ・ 富士莱 ・ 艾布鲁 ・ 格力博 ・ 恒工精密 ・ 海看股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies